• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE Back to Search Results
Model Number SGC0701
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 03/03/2022
Event Type  Injury  
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of thrombus is listed in the mitraclip g4 system instructions for use (ifu) as a known possible complication associated with mitraclip procedures.Based on available information, a cause for the reported thrombus could not be determined.The reported required medication is the result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.
 
Event Description
This is filed for thrombosis.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) of grade 4+.The patient was administered 5000 units of heparin and the activated clotting time (act) was greater than 400.The guide wire was advanced into the anatomy and across the septum without issue.The steerable guide catheter (sgc) was advanced into the patient anatomy without issue; however, when the sgc reached the right atrium, a large clot was noted on the guide wire in the right atrium.The sgc was removed and additional heparin was administered.The sgc was re-prepped for re-insertion; however, it was noted that the clot remained.A full dose of angiomax was administered, but the clot remained.The decision was made to abort the procedure and monitor the patient condition.At the end of the procedure, the patient was in stable condition.The plan is to have the patient return to the operating room for transesophageal echocardiogram (tee).If the clot remains, additional intervention will be performed.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G4 STEERABLE GUIDING CATHETER
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13896382
MDR Text Key288309587
Report Number2024168-2022-03152
Device Sequence Number1
Product Code DRA
UDI-Device Identifier08717648231025
UDI-Public08717648231025
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/24/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/21/2022
Device Model NumberSGC0701
Device Catalogue NumberSGC0701
Device Lot Number10922R248
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/03/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age88 YR
Patient SexMale
Patient Weight100 KG
-
-